Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Cell Biol Int. 2022 Jul;46(7):1009-1020. doi: 10.1002/cbin.11800. Epub 2022 Apr 2.
Almost a century after the devastating pandemic of the Spanish flu, humankind is facing the relatively comparable global outbreak of COVID-19. COVID-19 is an infectious disease caused by SARS-CoV-2 with an unprecedented transmission pattern. In the face of the recent repercussions of COVID-19, many have argued that the clinical experience with influenza through the last century may have tremendous implications in the containment of this newly emerged viral disease. During the last 2 years, from the emergence of COVID-19, tremendous advances have been made in diagnosing and treating coinfections. Several approved vaccines are available now for the primary prevention of COVID-19 and specific treatments exist to alleviate symptoms. The present review article aims to discuss the pathophysiology, diagnosis, and treatment of SARS-CoV-2 and influenza A virus coinfection while delivering a bioinformatics-based insight into this subject matter.
在西班牙流感大流行近一个世纪之后,人类正面临着 COVID-19 这一相对可比的全球疫情爆发。COVID-19 是由 SARS-CoV-2 引起的传染病,其传播模式前所未有。面对 COVID-19 的近期影响,许多人认为,上个世纪流感的临床经验可能对遏制这种新出现的病毒性疾病具有巨大影响。在过去的两年中,自 COVID-19 出现以来,在诊断和治疗合并感染方面取得了巨大进展。现在有几种经过批准的疫苗可用于预防 COVID-19,并且存在特定的治疗方法来缓解症状。本文综述的目的是讨论 SARS-CoV-2 和甲型流感病毒合并感染的病理生理学、诊断和治疗,并提供该主题的基于生物信息学的见解。